{
    "eid": "2-s2.0-85120050022",
    "title": "Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Chemoembolization",
        "Dexamethasone",
        "Double blind method",
        "Hepatocellular carcinoma",
        "Postembolization syndrome",
        "Prevention"
    ],
    "authors": [
        "Panot Sainamthip",
        "Chutcharn Kongphanich",
        "Naiyarat Prasongsook",
        "Sakkarin Chirapongsathorn"
    ],
    "citedby-count": 6,
    "ref-count": 22,
    "ref-list": [
        "A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma",
        "Diagnosis, incidence, and prevention of congenital toxoplasmosis",
        "Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand",
        "Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer",
        "Cytolysis following chemoembolization for hepatocellular carcinoma",
        "Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis",
        "Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria",
        "Postchemoembolisation syndrome\u2010\u2010tumour necrosis or hepatocyte injury?",
        "Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update",
        "Postembolization syndrome after hepatic transarterial chemoembolization: effect of prophylactic steroids on postprocedure medication requirements",
        "Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study",
        "A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization",
        "A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization",
        "Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases",
        "A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma",
        "Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade",
        "Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization",
        "Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial",
        "A dose ranging study of dexamethasone for preventing patient-controlled analgesia-related nausea and vomiting: a comparison of droperidol with saline",
        "Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications",
        "N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization",
        "Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital",
        "Mahidol University for English Language Editing",
        "Office of Research and Development Phramongkutklao College of Medicine"
    ]
}